Condition or disease | Intervention/treatment |
---|---|
Lymphoma | Radiation: diffusion weighted magnetic resonance image in lymphoma |
Lymphomas are the malignant tumors of lymph nodes and considered as one of the most common primary hematopoietic malignancy. Multi slice computed tomography is the most readily available and most commonly used tool for staging lymphoma. But it has multiple limitations in diagnosis of lymphoma as the recognition of lymph node involvement is based only on the size of the lymph node without any metabolic information .
The tumors rely on glucose as their substrate for energy production and replication, this metabolic information can be obtained from the 2-deoxy-2-fluoro-D-glucose Among the positron Emission Tomography Computed Tomography parameters, standardized uptake value is currently the most commonly used semi-quantitative index of 2-deoxy-2-fluoro-D-glucose metabolic rate. standardized uptake value reflects tumor glucose metabolism, and is commonly represented by the maximum standardized uptake value .2-deoxy-2-fluoro-D-glucose positron Emission Tomography Computed Tomography has been shown to be more accurate for the evaluation of the extent of disease and treatment response by providing these metabolic information in patients with malignant lymphoma .
2-deoxy-2-fluoro-D-glucose positron Emission Tomography Computed Tomography , with the advantage of being able to perform whole-body detection of malignant lesions, is considered to be the current standard of practice for the management of lymphomas; however, positron Emission Tomography Computed Tomography is expensive, time-consuming, involves exposure to ionizing radiation and is not widely available because it requires large and expensive equipment . In contrast, Magnetic Resonance Imaging provides excellent tissue contrast, high spatial resolution, detailed morphological information without the use of ionizing radiation . Diffusion-weighted Magnetic Resonance Imaging is a noninvasive technique allows visualization of diffusion properties of water molecules in biologic tissues. .
A supplemental tool in Diffusion-weighted imaging is the apparent diffusion coefficient map , acquired by post-processing of the obtained Diffusion-weighted images . apparent diffusion coefficient allows for quantitative definition of diffusion parameters (in mm2/sec) . Diffusion-weighted images with apparent diffusion coefficient mapping could provide useful functional information regarding the characterization of lymphomas .Because of their high cellularity and high nuclear-to-cytoplasm ratio .
Study Type : | Observational |
Estimated Enrollment : | 50 participants |
Observational Model: | Case-Crossover |
Time Perspective: | Cross-Sectional |
Official Title: | Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Evaluation of Patients With Malignant Lymphoma: Comparison With 2-deoxy-2-fluoro-D-glucose-positron Emission Tomography/Computed Tomography |
Estimated Study Start Date : | September 1, 2019 |
Estimated Primary Completion Date : | December 30, 2021 |
Estimated Study Completion Date : | January 30, 2022 |
Group/Cohort | Intervention/treatment |
---|---|
1 lymphoma patients
pre therapy and post therapy of lymphoma patients
|
Radiation: diffusion weighted magnetic resonance image in lymphoma
compare between result of positron emission tomography /computed tomography and diffusion weighted imaging in followup of lymphoma
|
Ages Eligible for Study: | 8 Years to 80 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Abouzeid Hazem, professor | 01005075888 | sarad423@yahoo.com | |
Contact: Khodary Omran, lecturer | omranshow@yahoo.com |
Principal Investigator: | sara, Msc | Assiut University |
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date | May 23, 2019 | ||||||||
First Posted Date | May 31, 2019 | ||||||||
Last Update Posted Date | May 31, 2019 | ||||||||
Estimated Study Start Date | September 1, 2019 | ||||||||
Estimated Primary Completion Date | December 30, 2021 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures |
role of diffusion weighted imaging in followup of lymphoma [ Time Frame: 5 minutes ] • measures mean Apparent diffusion coefficient value in pre and post therapy status in patients with lymphoma with cut off value 1 .
|
||||||||
Original Primary Outcome Measures | Same as current | ||||||||
Change History | No Changes Posted | ||||||||
Current Secondary Outcome Measures | Not Provided | ||||||||
Original Secondary Outcome Measures | Not Provided | ||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
Descriptive Information | |||||||||
Brief Title | Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Patients With Lymphoma | ||||||||
Official Title | Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Evaluation of Patients With Malignant Lymphoma: Comparison With 2-deoxy-2-fluoro-D-glucose-positron Emission Tomography/Computed Tomography | ||||||||
Brief Summary |
|
||||||||
Detailed Description |
Lymphomas are the malignant tumors of lymph nodes and considered as one of the most common primary hematopoietic malignancy. Multi slice computed tomography is the most readily available and most commonly used tool for staging lymphoma. But it has multiple limitations in diagnosis of lymphoma as the recognition of lymph node involvement is based only on the size of the lymph node without any metabolic information . The tumors rely on glucose as their substrate for energy production and replication, this metabolic information can be obtained from the 2-deoxy-2-fluoro-D-glucose Among the positron Emission Tomography Computed Tomography parameters, standardized uptake value is currently the most commonly used semi-quantitative index of 2-deoxy-2-fluoro-D-glucose metabolic rate. standardized uptake value reflects tumor glucose metabolism, and is commonly represented by the maximum standardized uptake value .2-deoxy-2-fluoro-D-glucose positron Emission Tomography Computed Tomography has been shown to be more accurate for the evaluation of the extent of disease and treatment response by providing these metabolic information in patients with malignant lymphoma . 2-deoxy-2-fluoro-D-glucose positron Emission Tomography Computed Tomography , with the advantage of being able to perform whole-body detection of malignant lesions, is considered to be the current standard of practice for the management of lymphomas; however, positron Emission Tomography Computed Tomography is expensive, time-consuming, involves exposure to ionizing radiation and is not widely available because it requires large and expensive equipment . In contrast, Magnetic Resonance Imaging provides excellent tissue contrast, high spatial resolution, detailed morphological information without the use of ionizing radiation . Diffusion-weighted Magnetic Resonance Imaging is a noninvasive technique allows visualization of diffusion properties of water molecules in biologic tissues. . A supplemental tool in Diffusion-weighted imaging is the apparent diffusion coefficient map , acquired by post-processing of the obtained Diffusion-weighted images . apparent diffusion coefficient allows for quantitative definition of diffusion parameters (in mm2/sec) . Diffusion-weighted images with apparent diffusion coefficient mapping could provide useful functional information regarding the characterization of lymphomas .Because of their high cellularity and high nuclear-to-cytoplasm ratio . |
||||||||
Study Type | Observational | ||||||||
Study Design | Observational Model: Case-Crossover Time Perspective: Cross-Sectional |
||||||||
Target Follow-Up Duration | Not Provided | ||||||||
Biospecimen | Not Provided | ||||||||
Sampling Method | Non-Probability Sample | ||||||||
Study Population | patients diagnosed as malignant lymphoma | ||||||||
Condition | Lymphoma | ||||||||
Intervention | Radiation: diffusion weighted magnetic resonance image in lymphoma
compare between result of positron emission tomography /computed tomography and diffusion weighted imaging in followup of lymphoma
|
||||||||
Study Groups/Cohorts | 1 lymphoma patients
pre therapy and post therapy of lymphoma patients
Intervention: Radiation: diffusion weighted magnetic resonance image in lymphoma
|
||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status | Not yet recruiting | ||||||||
Estimated Enrollment |
50 | ||||||||
Original Estimated Enrollment | Same as current | ||||||||
Estimated Study Completion Date | January 30, 2022 | ||||||||
Estimated Primary Completion Date | December 30, 2021 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Sex/Gender |
|
||||||||
Ages | 8 Years to 80 Years (Child, Adult, Older Adult) | ||||||||
Accepts Healthy Volunteers | No | ||||||||
Contacts |
|
||||||||
Listed Location Countries | Not Provided | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number | NCT03969381 | ||||||||
Other Study ID Numbers | lymphoma | ||||||||
Has Data Monitoring Committee | Not Provided | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement | Not Provided | ||||||||
Responsible Party | Sara Ali Gamal, Assiut University | ||||||||
Study Sponsor | Assiut University | ||||||||
Collaborators | Not Provided | ||||||||
Investigators |
|
||||||||
PRS Account | Assiut University | ||||||||
Verification Date | May 2019 |